Related Experiment Video
Updated: Jun 24, 2026
11:17
Thoracoscopic Extended Right Middle Plus Lower Sleeve Lobectomy for Non-Small-Cell Lung Cancer
Published on: February 27, 2026
Microthoracoscopic one-port method for lung cancer.
Masayuki Iwazaki1, Hiroshi Inoue
1Division of General Thoracic Surgery, Department of Surgery, Tokai University School of Medicine, Isehara, Kanagawa, Japan. iwasaki@is.icc.u-tokai.ac.jp
The Annals of Thoracic Surgery
|March 28, 2009
Summary
The one-window thoracoscopic method is a viable and minimally invasive surgical option for early-stage lung cancer, demonstrating successful outcomes and no recurrence in patients. This technique offers a less invasive approach to pulmonary cancer surgery.
Area of Science:
- Thoracic Surgery
- Surgical Oncology
- Minimally Invasive Surgery
Background:
- Thoracoscopic surgery is a common approach for lung cancer.
- The standard two-window method involves multiple incisions.
- Exploring less invasive techniques is crucial for patient recovery.
Purpose of the Study:
- To evaluate the feasibility of the one-window method for early-stage lung cancer surgery.
- To assess the safety and efficacy of this minimally invasive technique.
Main Methods:
- A cohort of 40 patients with stage IA lung cancer underwent thoracoscopic surgery.
- A specialized Thoraco Holder was used as a single port for surgical instruments.
- Pulmonary lobectomy and mediastinal lymph node dissection were performed using the one-window technique.
Main Results:
- The one-window method was successful in 38 out of 40 patients (95% success rate).
- Mean operative time was 2 hours and 18 minutes, with minimal blood loss (22 mL).
- All patients remained alive and recurrence-free at a minimum 5-year follow-up.
Conclusions:
- The one-window thoracoscopic method is a feasible and effective surgical approach for early-stage lung cancer.
- Mastery of the technique and instrument development have enabled its successful application.
- This method represents the least invasive option currently available for pulmonary cancer surgery.
